Nadolol and Bendroflumethiazide - NADOLOL and BENDROFLUMETHIAZIDE
Navigation: NDC > Supplier starting with: G > GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.| Field | Value |
|---|---|
| NDC Code: | 0115-5322 |
| Proprietary Name: | Nadolol and Bendroflumethiazide |
| Suffix: | |
| Non-Proprietary Name: | NADOLOL and BENDROFLUMETHIAZIDE |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 30-03-2007 |
| Category Name: | ANDA |
| Application Number: | ANDA077833 |
| Labeler: | GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC. |
| Substance Name: | BENDROFLUMETHIAZIDE; NADOLOL |
| Active Numerator Strength: | 5; 80 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |